CN Patent

CN111065382A — 塞来昔布和氨氯地平的配方及其制备方法

Assigned to Kiteward Pharmaceutical · Expires 2020-04-24 · 6y expired

What this patent protects

本文提供了塞来昔布和氨氯地平的组合物及其制备方法。该组合物包含含有塞来昔布的颗粒。氨氯地平以另外的颗粒的形式掺入到组合物中。

USPTO Abstract

本文提供了塞来昔布和氨氯地平的组合物及其制备方法。该组合物包含含有塞来昔布的颗粒。氨氯地平以另外的颗粒的形式掺入到组合物中。

Drugs covered by this patent

Patent Metadata

Patent number
CN111065382A
Jurisdiction
CN
Classification
—
Expires
2020-04-24
Drug substance claim
No
Drug product claim
No
Assignee
Kiteward Pharmaceutical
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.